Adding drug to standard chemo shows promise for women with triple-negative breast can

[News]

In a nationwide study of women with "triple-negative" breast cancer, adding the chemotherapy drug carboplatin or the angiogenesis inhibitor Avastin to standard chemotherapy drugs brought a sharp increase in the number of patients whose tumors shrank away completely, investigators reported at the 2013 San Antonio Breast Cancer Symposium.

More... (http://www.medicalnewstoday.com/releases/270228.php)